Initiating Coverage of Unitree Robotics: Cost Leadership and Rapid Iteration Support a Buy Thesis

Overview

Nomura initiates coverage of Unitree Robotics, positioning it as a leading player in China’s embodied intelligence sector. The report believes that the company has established cost and pricing advantages through full-stack in-house development of joint modules, motors, reducers, drivers, LiDAR, and structural components. Combined with a broad product portfolio spanning humanoid robots, quadruped robots, robotic arms, and dexterous hands, as well as a rapid iteration cycle, this should enable the company to expand its share during the robotics scaling phase.

Core views

The investment thesis rests on two pillars: first, vertical integration reduces bill-of-materials costs and supports low pricing, scaled delivery, and profitability; second, rapid iteration and early-mover product breadth enable the company to enter new application scenarios earlier. The report expects growth to be driven primarily by volume rather than pricing and views humanoid robots as the main growth engine. At the same time, current industry shipments reflect manufacturing capability more than stable productive demand, and repeat orders from unrelated industrial customers will be key to validating commercialization quality.

Analysis framework

The report employs top-down analysis of industry demand, policy, and technology pathways, combined with comparisons of the company’s cost structure, product iteration, shipments, and financial forecasts for valuation. It uses 2027 forecast price-to-sales as the core target-price anchor while incorporating uncertainty around overseas regulation and end-demand.

Methodology notes

• Valuation methodsPrice-to-sales (P/S) valuation

  Derives the target market capitalization and target price by multiplying 2027 forecast revenue by the target price-to-sales multiple.

  The report assigns a 25x 2027 forecast P/S multiple, above the approximately 9x average for Chinese robotics peers, citing the company’s pure-play robotics exposure, shipment leadership, and strong expected revenue growth.

• Fundamental analysisVertical integration and unit economics model

  Assesses the cost moat and scale effects through in-house production rate, externally procured cost share, gross margin, selling price, and shipment volume.

  The report emphasizes that high in-house production of core components lowers costs, while price reductions can expand demand and create a cycle of scale, data, and R&D.

• Industry researchDemand-realization validation

  Assesses commercialization maturity through end-demand structure, industrial-scenario ROI, MTBF, cycle time, and repeat orders.

  The report believes current demand remains skewed toward entertainment, consumer applications, government procurement, and education. Genuine industrial deployment and repeat orders from unrelated customers are key validation signals for profit realization.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• 688836.SS

  Core coverage target

  Strengths

  Full-stack in-house mechanical and hardware development, low externally procured costs, rapid product iteration, broad product portfolio, and leadership in scaled delivery and profitability.

  Weaknesses

  End-demand for humanoid robots remains concentrated in non-productive scenarios such as research, while industrial commercialization and the maturity of robot intelligence still require validation.

  Comparison

  The report believes the company merits a valuation premium versus peers due to its cost position, shipments, and product breadth; its 25x 2027 forecast P/S is above the approximately 9x average for Chinese robotics peers.

  Risks

  FCC regulatory restrictions on U.S. sales of new models, slowing overseas growth, competitive and pricing pressure, and weaker-than-expected industrial demand and repeat orders.

Key data

• RatingBuyNomura initiating coverage.
• Target priceCNY370Based on 25x 2027 forecast P/S.
• Potential upside145.4%Relative to the CNY150.80 reference price.
• 2025 revenueCNY1.699 billionValue presented in the report.
• 2026/2027/2028 forecast revenueCNY2.687 billion / CNY5.396 billion / CNY13.184 billionYear-on-year growth rates are 58.1% / 100.8% / 144.3%, respectively.
• FY25 core-business gross marginApproximately 60%Up from approximately 44% in FY22.
• 2025 humanoid robot shipments>5,500 unitsThe report states this is the highest globally.
• 2025 humanoid robot revenue share51.8%It has surpassed quadruped robots to become the largest revenue line.

Impact & implications

If the company continues converting its in-house core-component capabilities into low selling prices, scaled shipments, and high gross margins, its valuation premium will have fundamental support. Near-term stock catalysts mainly include humanoid robot sales volume, capacity ramp-up, commercial progress of WVLA2.0 and UnifoLM-X1-0, and industrial application deployment; however, valuation realization depends heavily on demand shifting from research and demonstration uses toward industrial procurement with verifiable returns on investment.

Risks

• The U.S. FCC Covered List and subsequent rules may restrict market access for newly developed models in the United States and raise requirements for compliance, bill-of-materials disclosure, and local responsible entities.
• Overseas revenue growth may slow due to policy and trade restrictions.
• Humanoid robot revenue still primarily comes from research institutions, and new high-quality growth scenarios and industrial demand may fall short of expectations.
• Intensifying industry competition may lead to price declines and margin pressure.
• Humanoid robots have not yet broadly reached the threshold for large-scale industrial customer procurement in terms of ROI, MTBF, cycle time, and reliability.
• Insufficient high-quality real-world interaction data may delay the maturity of embodied intelligence models and applications.

What to watch

• Repeat orders from unrelated customers for humanoid robots in manufacturing, logistics, 3C assembly, and other scenarios.
• Commercialization progress of WVLA2.0 and UnifoLM-X1-0 and their ability to drive new application scenarios.
• Humanoid robot shipments, average selling prices, gross margins, and capacity expansion progress.
• Changes in the share of humanoid robot revenue from research customers and non-productive applications.
• U.S. FCC rules, continuity of existing certifications, and overseas market revenue performance.
• The impact of core-component in-house production rates, bill-of-materials cost reductions, and pricing strategy on profitability.